News
Over 500 million people worldwide suffer from diabetes—a disease that contributes to major complications such as stroke, ...
New marker identifies the functional maturity and heterogeneity of stem cell–derived islet organoids
Over 500 million people worldwide suffer from diabetes-a disease that contributes to major complications such as stroke, ...
Ekaterine Berishvili, a surgeon turned tissue engineer, is now focused on developing bioartificial pancreases. She has honed ...
The findings of a new study lend support for type 1 diabetes autoantibody screening in people with other autoimmune ...
Researchers given funding to explore stem cell-based approaches for cystic fibrosis-related diabetes
Researchers receive funding for proof-of-principle experiments investigating potential of cell replacement therapies for ...
On a smoky Friday night in Humboldt, hundreds of patrons, twenty hardy runners, an organization of tireless volunteers, and ...
Original-Research: Sernova Biotherapeutics Inc - from First Berlin Equity Research GmbH02.06.2025 / 13:39 CET/CESTDissemination of a Research, transmitted by EQS News - a service of EQS Group.The ...
The risk of major cardiac events was 50% higher in adult-onset type 1 diabetes than in population controls, and the risk of ...
TIXiMED Announces Successful Completion of a Phase 1 Study of its Novel Oral Disease-Modifying Type 1 Diabetes Therapy, ...
Breakthrough T1D, formerly JDRF, the leading global type 1 diabetes (T1D) research and advocacy organization, is pleased to announce two exciting developments at the Breakthrough T1D Center of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results